Clinical Trials Directory

Trials / Unknown

UnknownNCT02761941

Excessive Warfarin Anticoagulation - Causes and Consequences

Status
Unknown
Phase
Study type
Observational
Enrollment
25,000 (estimated)
Sponsor
University of Turku · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the clinical significance of high INR (International Normalized Ratio) values (\>9) in VKA (vitamin K antagonist) treated patients with atrial fibrillation. The clinical characteristics of these patients will be studied as well as the clinical presentation. Factors influencing on high INR values will be recorded and the aim is to seek out patients who have elevated risk of bleeding complications.

Detailed description

This is a retrospective study setting. Source data will be collected by reviewing medical records and through computer searches. The basic study population will be identified from laboratory INR test results taken between 2003-2015. Identifying patients with INR values over 9 will be selected for further analysis, concerning the clinical presentation, patient characteristics, 90 day survival and adverse event rates. The focus is in identifying patient characteristics and factors influencing the risk of high INR value. Also we will analyse the effects of medically reversing the high INR values on stroke and other adverse event rates. The results will be collected manually using an electronic case report form, and analysed statistically using SPSS/SAS statistics tool.

Conditions

Timeline

Start date
2016-05-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2016-05-04
Last updated
2016-05-05

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02761941. Inclusion in this directory is not an endorsement.

Excessive Warfarin Anticoagulation - Causes and Consequences (NCT02761941) · Clinical Trials Directory